BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20074670)

  • 41. Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice.
    Kang JS; Yoon WK; Youm JK; Jeong SK; Park BD; Han MH; Lee H; Moon EY; Han SB; Lee CW; Lee K; Park SK; Yang KH; Kim HM
    Exp Dermatol; 2008 Nov; 17(11):958-64. PubMed ID: 18721197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis.
    Jensen JM; Scherer A; Wanke C; Bräutigam M; Bongiovanni S; Letzkus M; Staedtler F; Kehren J; Zuehlsdorf M; Schwarz T; Weichenthal M; Fölster-Holst R; Proksch E
    Allergy; 2012 Mar; 67(3):413-23. PubMed ID: 22142306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice.
    Kang JS; Lee K; Han SB; Ahn JM; Lee H; Han MH; Yoon YD; Yoon WK; Park SK; Kim HM
    Int Immunopharmacol; 2006 Oct; 6(10):1616-22. PubMed ID: 16919834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis.
    Xhauflaire-Uhoda E; Thirion L; Piérard-Franchimont C; Piérard GE
    Dermatology; 2007; 214(4):328-32. PubMed ID: 17460405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study.
    Caproni M; Torchia D; Antiga E; Terranova M; Volpi W; del Bianco E; D'Agata A; Fabbri P
    Br J Dermatol; 2007 Feb; 156(2):312-9. PubMed ID: 17223872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epicutaneous sensitization with ovalbumin, staphylococcal enterotoxin B and vitamin D analogue induces 
atopic dermatitis in mice.
    Tan L; Lu J; Chen M; Xiang Y; Cheng Q; Liang Y; Huang J; Huang J; Chen J; Gao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1023-1029. PubMed ID: 28989146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice.
    Noguchi A; Tominaga M; Takahashi N; Matsuda H; Kamata Y; Umehara Y; Ko KC; Suga Y; Ogawa H; Takamori K
    J Dermatol Sci; 2017 Apr; 86(1):54-62. PubMed ID: 28069324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
    Jensen JM; Pfeiffer S; Witt M; Bräutigam M; Neumann C; Weichenthal M; Schwarz T; Fölster-Holst R; Proksch E
    J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rutin suppresses atopic dermatitis and allergic contact dermatitis.
    Choi JK; Kim SH
    Exp Biol Med (Maywood); 2013 Apr; 238(4):410-7. PubMed ID: 23760007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
    Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M; Steinhoff M; Schneider D; Luger TA
    Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism.
    Yu J; Oh MH; Park JU; Myers AC; Dong C; Zhu Z; Zheng T
    PLoS One; 2012; 7(7):e39032. PubMed ID: 22848348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical application of FK506 (tacrolimus) ointment inhibits mite antigen-induced dermatitis by local action in NC/Nga mice.
    Sasakawa T; Higashi Y; Sakuma S; Hirayama Y; Sasakawa Y; Ohkubo Y; Mutoh S
    Int Arch Allergy Immunol; 2004 Jan; 133(1):55-63. PubMed ID: 14726632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.
    Thaçi D; Salgo R
    Clin Dermatol; 2010; 28(1):52-6. PubMed ID: 20082951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
    Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
    J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential requirements for interleukin (IL)-4 and IL-13 in protein contact dermatitis induced by Anisakis.
    Nieuwenhuizen N; Herbert DR; Brombacher F; Lopata AL
    Allergy; 2009 Sep; 64(9):1309-18. PubMed ID: 19254288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.
    Jensen JM; Ahrens K; Meingassner J; Scherer A; Bräutigam M; Stütz A; Schwarz T; Fölster-Holst R; Harder J; Gläser R; Proksch E
    Exp Dermatol; 2011 Oct; 20(10):783-8. PubMed ID: 21707760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.